Sponsor:
Washington University School of Medicine
Code:
NCT07916883
Conditions
Carotid Atherosclerosis
Carotid Artery Stenosis Asymptomatic
Asymptomatic Carotid Artery Stenosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
64Cu-NODAGA-CANF
Optimal Medical Therapy (OMT)
Carotid Endarterectomy (CEA) surgery
Brief summary:
Conditions
Carotid Atherosclerosis
Carotid Artery Stenosis Asymptomatic
Asymptomatic Carotid Artery Stenosis
Study ID
NCT07916883
Start date
Nov 18, 2026
Status verified date
Nov, 2026
Completion date
May 31, 2027
Anticipated
Primary completion date
May 31, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
30 participants
Anticipated
Arms
Patients treated with Optimal Medical Therapy (OMT) alone
Patients treated with OMT and carotid endartarectomy (CEA)
Interventions
64Cu-NODAGA-CANF
Optimal Medical Therapy (OMT)
Carotid Endarterectomy (CEA) surgery
Primary outcome measure
Central contacts
Locations
Washington University School of Medicine
Recruiting
St Louis, Missouri, United States, 63110
Contacts
Principal Investigator:
Pamela K. Woodard, MD
Sponsor
Washington University School of Medicine
Last update posted
Nov 18, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Washington University School of Medicine on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.